M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Roach, MD
Momenta Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Ottawa Hospital Cancer Center
Ottawa, Ontario, Canada
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Chum Hospital St-Luc
Montreal, Quebec, Canada
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Clearview Cancer Institute
Huntsville, Alabama, United States
- Arizona Clinical Research Center
Tucson, Arizona, United States
- University of Arizona
Tucson, Arizona, United States
- University of Colorado School of Medicine - Division of Medical Oncology
Aurora, Colorado, United States
- Poudre Valley Health System
Fort Collins, Colorado, United States
- Hartford Healthcare Cancer Institute at Midstate Medical Center
Meriden, Connecticut, United States
- Florida Hospital Tampa
Tampa, Florida, United States
- Southeastern Regional Medical Center
Newnan, Georgia, United States
- Illinois Cancer Specialists
Arlington Heights, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Crescent City Research Consortium
Marrero, Louisiana, United States
- Ochsner Medical Center
New Orleans, Louisiana, United States
- University of Maryland- St Joseph'S Medical Center
Towson, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Umass Memorial Medical Center
Worcester, Massachusetts, United States
- St. Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Karmanos Cancer Center
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro-Minnesota Community Clinical Oncology Program
Saint Louis Park, Minnesota, United States
- University of Kansas Cancer Center
Kansas City, Missouri, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Montefiore-Einstein Center for Cancer Care
The Bronx, New York, United States
- Ohio State University
Columbus, Ohio, United States
- Northwest Cancer Specialists
Portland, Oregon, United States
- Penn State Hershey Cancer Center
Hershey, Pennsylvania, United States
- Cancer Center of the Carolinas/itor
Greenville, South Carolina, United States
- University of Texas Health Sciences Center
San Antonio, Texas, United States
- Texas Oncology
Tyler, Texas, United States
- Texas Oncology, P.A.
Tyler, Texas, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- 24 Oct 2016
- Completion
- 24 Oct 2016
- Last update posted
- 29 Aug 2018
- Registered enrollment
- 128
- Registry id
- NCT01621243
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.